Progesterone vaginal ring

Source: Wikipedia, the free encyclopedia.
Not to be confused with Ethinylestradiol/etonogestrel.
Progesterone vaginal ring
birth control vaginal ring
Background
TypeHormonal
First use1998
Trade namesProgering, Fertiring, others
Failure rates (first year)
Perfect use?
Typical use1.5%[1]
Usage
Duration effect3 months
User reminders?
Advantages and disadvantages
STI protectionNo[2]
Period advantagesPeriods may not occur while ring is inserted
BenefitsEasy insertion and removal[3]

Progesterone vaginal ring, also known as progesterone-only vaginal ring, is a form of vaginal ring used for birth control when breastfeeding.[1] Use can begin at four weeks and continue for at least up to a year following childbirth.[4][3] Failure rates with usual use is about 1.5 per 100 women.[1] It is used within the vagina with one ring lasting three months.[4] The woman is able to place and remove the ring herself.[3] It is sold under the brand names Progering among others.[5]

Side effects include vaginal discharge and pain with urination.[3] It does not appear to be associated with serious side effects.[3][6] With use menstrual periods often do not resume.[1] It was specifically made for use with breastfeeding as it does not affect milk production.[1] It works by gradually releasing the hormone progesterone.[1]

Progesterone vaginal rings have been approved for medical use since 1998.

Central American countries.[1] As of 2016, it is not available in the United States.[4] It was developed by the Population Council.[5][2]

See also

References

  1. ^
    ISBN 9781461465799. Archived
    from the original on 2016-12-29.
  2. ^ a b c "Progesterone Vaginal Ring" (PDF). PATH. Archived (PDF) from the original on 5 November 2017. Retrieved 28 December 2016.
  3. ^
    ISSN 0512-3054
    . WHO technical report series;994.
  4. ^
    ISBN 9781284081541. Archived
    from the original on 2016-12-28.
  5. ^ a b "Population Council's Progesterone Contraceptive Vaginal Ring Added to WHO 2015 Essential Medicines List and Included in Medical Eligibility Criteria Guidance for Providers | Population Council". www.popcouncil.org. 9 June 2015. Archived from the original on 29 December 2016. Retrieved 28 December 2016.
  6. PMID 25869631
    .
  7. hdl:10665/325771
    . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  8. hdl:10665/345533
    . WHO/MHP/HPS/EML/2021.02.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Progesterone_vaginal_ring&oldid=1136146826"